Skip to main content
Premium Trial:

Request an Annual Quote

BGI and Affymetrix to Co-Develop Microarrays for Agricultural Market

Premium

Affymetrix and China's BGI are collaborating on developing and marketing a portfolio of plant, crop, and livestock microarrays for genotyping, the organizations said last week.

Under the strategic partnership, which is non-exclusive, BGI will provide access to genomic markers from its 1000 Plant and Animal Reference Genomes Project, which started in 2010.

The arrays will be "spanning applications such as marker-assisted trait selection, parentage, quality control, and traceability," according to the partners.

The collaboration is notable because BGI has a strong relationship with Affy's rival in the microarray market, Illumina. Two years ago, BGI purchased 128 of Illumina's HiSeq 2000 sequencing systems.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.